XML 40 R32.htm IDEA: XBRL DOCUMENT v3.22.4
Stockholders’ (Deficit) Equity
3 Months Ended
Sep. 30, 2022
Equity [Abstract]  
Stockholders’ (Deficit) Equity

26. Stockholders’ (Deficit) Equity

 

The Company is authorized to issue 10,000,000,000 shares of $0.001 par value common stock and 10,000,000 shares of $0.001 par value preferred stock. On April 22, 2020, the Company filed an amendment to increase the total authorized shares to 10,010,000,00010,000,000,000 of which are designated as common stock, par $0.001 per share and 10,000,000 of which are designated as preferred stock, par value $0.001 per share. On March 2, 2022, the Company filed with the Delaware Secretary of State a certificate of amendment (the “Amendment”) to the Company’s certificate of incorporation (the “Certificate of Incorporation”). The Amendment had the effect of increasing the Company’s authorized common stock from 10,000,000,000 shares to 20,000,000,000 shares.

 

Share issuances during the three months ended September 30, 2022

 

During the three months ended September 30, 2022, the Company issued 154,755,162 shares of common stock for total cash of $19,360.

 

During the three months ended September 30, 2022, the Company fully collected the total subscription receivable of $10,042.

 

As of September 30, 2022 and June 30, 2022, the Company had 11,980,144,738 and 11,825,389,576 shares of its common stock issued and outstanding, respectively.

 

As of September 30, 2022 and June 30, 2022, the Company had 2,541,500 shares and 2,541,500 shares of its series B preferred stock issued and outstanding, respectively.

 

As of September 30, 2022 and June 30, 2022, the Company had 1 share of its series C preferred stock issued and outstanding, respectively.